Anika Therapeutics Inc. (ANIK) earnings
ANIK earnings moved a median of -0.64% by the close. Quarterly and annual ANIK reports and results, each read against the price at its own news timestamp. Back to the ANIK overview →
30 measured ANIK earnings events.
Where these ANIK earnings landedvs 30 measured ANIK earnings reactions
| Middle 50% of ANIK earnings reactions | -6.15% to +0.91% |
|---|---|
| Median reaction (to close) | -0.64% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 ANIK earnings events with a measured close landed between -6.15% and +0.91%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Anika Reports Second Quarter 2026 Financial Results | Press release | -2.79% | -6.15% | |
| Form 10-Q Anika Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +6.84% | +9.45% | |
| Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 | Press release | +0.00% | -0.88% | |
| Form 10-Q Anika Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.32% | -0.40% | |
| Anika Reports First Quarter 2026 Financial Results | Press release | -3.44% | -18.75% | |
| Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 | Press release | -0.52% | +1.25% | |
| Form 10-K Anika Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.31% | +0.91% | |
| Anika Reports Third Quarter 2025 Financial Results | Press release | -1.13% | -6.90% | |
| Form 10-Q Anika Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.86% | -1.22% | |
| Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 | Press release | +0.00% | +2.88% | |
| Anika Reports Second Quarter 2025 Financial Results | Press release | -1.11% | -10.20% | |
| Form 10-Q Anika Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.62% | +1.91% | |
| Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 | Press release | +0.14% | +0.90% | |
| Anika Reports First Quarter 2025 Financial Results | Press release | -1.44% | -8.99% | |
| Form 10-Q Anika Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.04% | -2.76% | |
| Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 | Press release | +0.00% | +0.91% | |
| Form 10-K Anika Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.88% | +0.75% | |
| Form 10-Q Anika Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.41% | -5.07% | |
| Anika Reports Third Quarter 2024 Financial Results | Press release | -6.59% | -29.06% | |
| Anika Announces Third Quarter 2024 Results Conference Call Date | Press release | +0.00% | -0.91% | |
| Anika Reports Second Quarter 2024 Financial Results | Press release | +0.00% | +1.95% | |
| Form 10-Q Anika Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.95% | |
| Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 | Press release | -0.14% | +0.75% | |
| Anika Reports First Quarter 2024 Financial Results | Press release | -2.15% | -6.13% | |
| Form 10-Q Anika Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.15% | -6.13% | |
| Form 10-K/A Anika Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.08% | |
| Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 | Press release | +0.00% | +1.41% | |
| Form 10-K Anika Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.32% | +0.16% | |
| Form 10-Q Anika Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.93% | -12.76% | |
| Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business | Press release | -2.93% | -12.76% |
Keep exploring
More ANIK: analyst actions → · SEC filings → · ANIK overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. - Common Shares (XENE) | 276 | +0.03% | 50% |
| Aclaris Therapeutics, Inc. (ACRS) | 275 | 0.00% | 48% |
| Delcath Systems, Inc. (DCTH) | 275 | -0.27% | 42% |
| Evolus, Inc. (EOLS) | 275 | +0.08% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.